1. Grinsztejn B, Hosseinipour M, Ribaudo H, Swindells S, Eron J, Chen Y, Wang L, Ou S, Anderson M, McCauley M et al: Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. The Lancet Infectious diseases 2014, 14(4):281-290.
2. Lundgren J, Babiker A, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper D, Fätkenheuer G, Llibre J et al: Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. The New England journal of medicine 2015, 373(9):795-807.
3. Pierre S, Jannat-Khah D, Fitzgerald D, Pape J, McNairy M: 10-Year Survival of Patients with AIDS Receiving Antiretroviral Therapy in Haiti. The New England journal of medicine 2016, 374(4):397-398.
4. Melgar M, Nichols C, Cavanaugh J, Kirking H, Surie D, Date A, Ahmedov S, Maloney S, Fukunaga R: Tuberculosis Preventive Treatment Scale-Up Among Antiretroviral Therapy Patients - 16 Countries Supported by the U.S. President's Emergency Plan for AIDS Relief, 2017-2019. MMWR Morbidity and mortality weekly report 2020, 69(12):329-334.
5. Ganatra S, Bucşan A, Alvarez X, Kumar S, Chatterjee A, Quezada M, Fish A, Singh D, Singh B, Sharan R et al: Antiretroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV coinfection model. The Journal of clinical investigation 2020, 130(10):5171-5179.
6. Guihot A, Bourgarit A, Carcelain G, Autran B: Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus. Trends in immunology 2011, 32(3):131-137.
7. Autran B, Carcelaint G, Li TS, Gorochov G, Blanc C, Renaud M, Durali M, Mathez D, Calvez V, Leibowitch J et al: Restoration of the immune system with anti-retroviral therapy. Immunology letters 1999, 66(1-3):207-211.
8. Grabar S, Le Moing V, Goujard C, Leport C, Kazatchkine M, Costagliola D, Weiss L: Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Annals of internal medicine 2000, 133(6):401-410.
9. Yang X, Su B, Zhang X, Liu Y, Wu H, Zhang T: Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: Challenges of immunological non-responders. Journal of leukocyte biology 2020, 107(4):597-612.
10. Powderly W, Landay A, Lederman M: Recovery of the immune system with antiretroviral therapy: the end of opportunism? JAMA 1998, 280(1):72-77.
11. Engsig F, Gerstoft J, Kronborg G, Larsen C, Pedersen G, Røge B, Jensen J, Nielsen L, Obel N: Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study. BMC infectious diseases 2010, 10:318.
12. Monforte A, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F, Kirk O, Law M, De Wit S, Friis-Møller N et al: HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS (London, England) 2008, 22(16):2143-2153.
13. Bowen L, Smith B, Reich D, Quezado M, Nath A: HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment. Nature reviews Neurology 2016, 12(11):662-674.
14. Tan I, Smith B, von Geldern G, Mateen F, McArthur J: HIV-associated opportunistic infections of the CNS. The Lancet Neurology 2012, 11(7):605-617.
15. Picat M, Lewis J, Musiime V, Prendergast A, Nathoo K, Kekitiinwa A, Nahirya Ntege P, Gibb D, Thiebaut R, Walker A et al: Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study. PLoS medicine 2013, 10(10):e1001542.
16. Cribbs S, Crothers K, Morris A: Pathogenesis of HIV-Related Lung Disease: Immunity, Infection, and Inflammation. Physiological reviews 2020, 100(2):603-632.
17. Baker J, Peng G, Rapkin J, Abrams D, Silverberg M, MacArthur R, Cavert W, Henry W, Neaton J: CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS (London, England) 2008, 22(7):841-848.
18. Kelley C, Kitchen C, Hunt P, Rodriguez B, Hecht F, Kitahata M, Crane H, Willig J, Mugavero M, Saag M et al: Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009, 48(6):787-794.
19. Shive C, Mudd J, Funderburg N, Sieg S, Kyi B, Bazdar D, Mangioni D, Gori A, Jacobson J, Brooks A et al: Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease. The Journal of infectious diseases 2014, 210(4):619-629.
20. Awad W, Ler G, Xu W, Keller A, Mak J, Lim X, Liu L, Eckle S, Le Nours J, McCluskey J et al: The molecular basis underpinning the potency and specificity of MAIT cell antigens. Nature immunology 2020, 21(4):400-411.
21. Le Bourhis L, Martin E, Péguillet I, Guihot A, Froux N, Coré M, Lévy E, Dusseaux M, Meyssonnier V, Premel V et al: Antimicrobial activity of mucosal-associated invariant T cells. Nature immunology 2010, 11(8):701-708.
22. Toubal A, Nel I, Lotersztajn S, Lehuen A: Mucosal-associated invariant T cells and disease. Nature reviews Immunology 2019, 19(10):643-657.
23. Legoux F, Bellet D, Daviaud C, El Morr Y, Darbois A, Niort K, Procopio E, Salou M, Gilet J, Ryffel B et al: Microbial metabolites control the thymic development of mucosal-associated invariant T cells. Science (New York, NY) 2019, 366(6464):494-499.
24. Koay H, Gherardin N, Enders A, Loh L, Mackay L, Almeida C, Russ B, Nold-Petry C, Nold M, Bedoui S et al: A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage. Nature immunology 2016, 17(11):1300-1311.
25. Jeffery H, van Wilgenburg B, Kurioka A, Parekh K, Stirling K, Roberts S, Dutton E, Hunter S, Geh D, Braitch M et al: Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1. Journal of hepatology 2016, 64(5):1118-1127.
26. Legoux F, Salou M, Lantz O: MAIT Cell Development and Functions: the Microbial Connection. Immunity 2020, 53(4):710-723.
27. Butler A, Hoffman P, Smibert P, Papalexi E, Satija R: Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nature biotechnology 2018, 36(5):411-420.
28. Qiu X, Hill A, Packer J, Lin D, Ma Y, Trapnell C: Single-cell mRNA quantification and differential analysis with Census. Nature methods 2017, 14(3):309-315.
29. Zhang X, Lan Y, Xu J, Quan F, Zhao E, Deng C, Luo T, Xu L, Liao G, Yan M et al: CellMarker: a manually curated resource of cell markers in human and mouse. Nucleic acids research 2019, 47:D721-D728.
30. Milasta S, Dillon C, Sturm O, Verbist K, Brewer T, Quarato G, Brown S, Frase S, Janke L, Perry S et al: Apoptosis-Inducing-Factor-Dependent Mitochondrial Function Is Required for T Cell but Not B Cell Function. Immunity 2016, 44(1):88-102.
31. Bock F, Tait S: Mitochondria as multifaceted regulators of cell death. Nature reviews Molecular cell biology 2020, 21(2):85-100.
32. Liang J, Cao R, Wang X, Zhang Y, Wang P, Gao H, Li C, Yang F, Zeng R, Wei P et al: Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2. Cell research 2017, 27(3):329-351.
33. Katz I, Leister E, Kacanek D, Hughes M, Bardeguez A, Livingston E, Stek A, Shapiro D, Tuomala R: Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study. Annals of internal medicine 2015, 162(2):90-99.
34. Lewden C, Chene G, Morlat P, Raffi F, Dupon M, Dellamonica P, Pellegrin JL, Katlama C, Dabis F, Leport C: HIV-Infected Adults With a CD4 Cell Count Greater Than 500 Cells/mm^3 on Long-Term Combination Antiretroviral Therapy Reach Same Mortality Rates as the General Population. JAIDS -HAGERSTOWN MD- 2007.
35. Ahuja S, Kulkarni H, Catano G, Agan B, Camargo J, He W, O'Connell R, Marconi V, Delmar J, Eron J et al: CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals. Nature medicine 2008, 14(4):413-420.
36. Younes S, Talla A, Pereira Ribeiro S, Saidakova E, Korolevskaya L, Shmagel K, Shive C, Freeman M, Panigrahi S, Zweig S et al: Cycling CD4+ T cells in HIV-infected immune nonresponders have mitochondrial dysfunction. The Journal of clinical investigation 2018, 128(11):5083-5094.
37. Scherpenisse M, Kootstra N, Bakker M, Berkhout B, Pasternak A: Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy. mBio 2021, 12(2).
38. HIV Infection Masquerading as Monoclonal Gammopathy of Unknown Significance. N Engl J Med 2003, 349(24):2362-2363.